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Abstract: The present work studies the functional behavior of novel poly(ε-caprolactone) (PCL)
membranes functionalized with reduced graphene oxide (rGO) nanoplatelets under simulated in vitro
culture conditions (phosphate buffer solution (PBS) at 37 ◦C) during 1 year, in order to elucidate their
applicability as scaffolds for in vitro neural regeneration. The morphological, chemical, and DSC
results demonstrated that high internal porosity of the membranes facilitated water permeation and
procured an accelerated hydrolytic degradation throughout the bulk pathway. Therefore, similar
molecular weight reduction, from 80 kDa to 33 kDa for the control PCL, and to 27 kDa for PCL/rGO
membranes, at the end of the study, was observed. After 1 year of hydrolytic degradation, though
monomers coming from the hydrolytic cleavage of PCL diffused towards the PBS medium, the pH
was barely affected, and the rGO nanoplatelets mainly remained in the membranes which envisaged
low cytotoxic effect. On the other hand, the presence of rGO nanomaterials accelerated the loss of
mechanical stability of the membranes. However, it is envisioned that the gradual degradation of the
PCL/rGO membranes could facilitate cells infiltration, interconnectivity, and tissue formation.
Keywords: hydrolytic bulk degradation mechanism; in vitro human neural models; neural tissue
regeneration; poly (ε-caprolactone); reduced graphene oxide
1. Introduction
In the recent years, there has been an increased interest in the functionalization of
biocompatible polymers traditionally used for biomedical applications and FDA approved, such as
poly(ε-caprolactone) (PCL), in order to incorporate different chemical, mechanical, or electrical stimuli,
and therefore converting these polymers from plain cell supports to tissue regenerative inductive
materials [1,2]. Different strategies have been used to introduce functional cues into polymers: loading
with protein and growth factors [3,4], polymer blending or copolymerization [5,6], and the formation
of composites with different types of nanomaterials [7–9] are among the most popular approaches.
Particularly, while under the shadow of certain controversy, graphene and graphene derivatives, as
graphene oxide (GO), have been studied to exploit their peculiar properties: capacity to interact with
biomolecules, cells, and tissues, and to enhance the mechanical, electrical, and/or magnetic properties
of polymer–graphene composite materials [10,11]. Moreover, graphene has demonstrated the potential
to direct differentiation into neural cell lineages of numerous stem cell types, such as embryonic stem
cells (ESCs), neural stem cells (NSCs), mesenchymal stem cells (MSCs), and induced pluripotent stem
cells (iPSCs) [12].
PCL is a semi-crystalline and hydrophobic aliphatic polyester, biocompatible and bioresorbable.
It has received a great attention for biomedical applications as an implantable biomaterial for sutures,
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wound dressing, and scaffolds for tissue repair [13,14]. In our previous works [15,16], flat membranes
of plain PCL, PCL/GO, and PCL/partially reduced graphene oxide (rGO) were developed by a facile
phase inversion fabrication method using nontoxic reagents. The membranes showed high porous
morphology that provided favorable nutrient transport properties, as well as suitable cell adhesion
and proliferation, particularly, PCL with graphene based nanoplatelets. Furthermore, the introduction
of rGO into the PCL matrix enhanced the nutrient transport properties, which suggested the
increased water wettability of the membranes. Therefore, the PCL/rGO membranes were considered
to have great potential to act as scaffolds for neural cells in perfusion bioreactors, in particular,
for the regeneration of neural tissue from stem cells from human origin to fabricate in vitro human
neural models.
After figuring out the promising properties exhibited by the PCL/rGO membranes and
accounting for their use in neural models, the study of the in vitro hydrolytic degradation route
and stability behavior of these innovative membranes, as a non-permanent scaffolding material,
is crucial. Ideal scaffolds should maintain their properties for sufficient time to complete their
function [17]. PCL is a long-term stable polymer when subjected to hydrolytic degradation
conditions, and therefore requires 2–4 years for its complete degradation, depending on the starting
molecular weight of the PCL [14]. However, it has been widely observed that the incorporation
of carbon based nanomaterials into the polymer matrix on the hydrolytic degradation alters the
degradability of the polymeric matrix. For instance, Duan et al. [18] observed the enhancement of the
wettability of a poly(L-lactide)(PLLA)-GO composite, a behavior that was ascribed to the presence
of oxygen-containing groups on the surface of the GO nanoplatelets, facilitated the scission of the
polymer macromolecular chains, and consequently, the scaffolds experienced a faster hydrolytic
degradation. Similar behavior was observed by Zhao et al. [19], who developed nanocomposites
of PLLA with multiwalled carbon nanotubes (MWNTs). Nevertheless, the literature also provides
studies showing that the incorporation of graphene nanoplatelets into the polymer matrix produced
the opposite effect, i.e., a reduction of the biodegradation rate of the material, due to the hydrophobic
constitution of graphene [20,21]. Recently, Murray et al. [21] reported the enzymatic degradation of
PCL/rGO mixtures and composites. On the one hand, the presence of rGO below 5 w/w % did not
significantly influence the enzymatic degradation kinetics. On the other hand, rGO incorporation above
5 w/w % in the PCL/rGO composites caused a deceleration of the enzymatic degradation. This was
attributed to the higher hydrophobicity of the composite PCL/rGO materials. While enzymatic
degradation facilitates the analysis of the degradation changes on the non-permanent polymer devices
under acceptable timeframes, long-term hydrolytic studies simulate physiological conditions more
adequately. However, it has been demonstrated that accelerated enzymatic studies of PCL scaffolds
led to very different degradation mechanisms, and consequently functional properties, than long-term
hydrolytic degradation [22]. To the best of our knowledge, the long-term hydrolytic degradation of
PCL/graphene composites or blends has not been reported so far.
The aim of this work consisted in the study of the long-term hydrolytic degradation of mixed
matrix membranes of PCL/rGO [16]. Also, plain PCL membranes under hydrolytic degradation were
evaluated and compared. In vitro conditions were simulated by immersion of the membranes in a
phosphate buffer solution (PBS, pH 7.4) at 37 ◦C. The evolution of the functional, morphological,
chemical, and thermal characteristics of the PCL/rGO membranes was evaluated during a period
of 1 year. A degradation kinetics and hydrolytic pathway of the membranes were proposed and
their structural stability was analyzed. Additionally, the degradation products during the study were
monitored in order to elucidate potential effects on cell cytotoxicity.
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2. Materials and Methods
2.1. Membrane Preparation
PCL pellets (average molecular weight, 80 kDa; Sigma-Aldrich, Madrid, Spain) were used to
fabricate PCL/rGO membranes using a phase inversion technique. The synthesis of rGO particles
adapted from Ribao et al. [23], as well as the fabrication of the membranes, was described in detail
in our previous work [16]. Control PCL membranes without rGO nanoplatelets were also prepared
for comparison.
Hydrolytic degradation experiments were performed on PCL/rGO and PCL membranes working
under simulated in vitro bioreactor conditions. A sufficient number of membranes were submerged
in a phosphate buffer solution (PBS, pH 7.4) and placed in an incubator at 37 ◦C. Separate solutions
were used for testing PCL/rGO and PCL membranes. Samples were taken out of the solution for
characterization at predetermined degradation time intervals: 0, 2, 4, 6, 9, and 12 months. PBS was
prepared as follows: 8 g of NaCl, 0.2 g of KCl, 1.44 g of Na2HPO4, and 0.24 g of KH2PO4 were
solubilized in 800 mL of distilled water. Then, the pH was adjusted to 7.4 with HCl (0.1 mol/L) and
made up to 1 L with distilled water. PBS was autoclaved for sterilization. The membranes were
sterilized by immersion in ethanol/water 70/30 v/v % and subsequent exposure to UV light for 20 min
in a laminar cabinet.
2.2. Characterization
2.2.1. Functional Properties
Axial tensile tests of the membranes were done using a servo-hydraulic testing universal
machine (ME-400, SERVOSIS, Madrid, Spain) following the ISO standard for thin plastic membranes
(ASTM D882-12). The specimens had an area of 40 × 6 mm2, and the tests were carried out using a
load cell of 1.25 kN at a constant elongation speed of 8 mm/s.
A tangential flow filtration system was used to characterize the flux of nutrients across the
membranes. The cross-flow filtration set up was already defined in our previous work [16].
A model feed solution was prepared, consisting of protein bovine serum albumin (BSA, >96% purity,
Sigma-Aldrich) at 0.4 g/L in PBS (pH 7.4). The membrane was previously stabilized with ultrapure
(UP) water at 0.1 bar for 1 h. Afterwards, the BSA model solution was circulated throughout the feed
compartment of the membrane cell, and a transmembrane pressure of 0.1 bar was applied during 4 h
of operation. The permeate solution was collected and weighed while the retentate was recirculated to
the feed tank. The change with time (t) of total BSA solution flux (JT (L·m−2·h−1)) was determined as
JT =
(
WT,permeated × ρPBS,37◦C
)
/(∆t× Ae) (1)
where WT,permeated (g) is the mass of permeate collected in the time interval ∆t (h) and using an effective
surface area Ae (m2), and ρPBS,37◦C (g·L−1) the PBS density at 37 ◦C. At least two membrane replicates
were analyzed for each degradation time.
2.2.2. Physical–Chemical Properties
The average molecular weight of the membranes was determined by gel permeation
chromatography (GPC model 510, Waters, Madrid, Spain). Three size exclusion chromatography
columns of styrene divinyl benzene copolymer were placed in series (model Styragel HR 5E, Waters)
and a refractometer (model 410, Waters) was used for detection. The columns were thermostatized
at 40 ◦C, and the measurements were carried out using 1 mL/min of tetrahydrofuran (THF 99.9%,
Panreac, Barcelona, Spain) as carrier. Membrane samples were solubilized in THF at a concentration of
0.5 mg/mL. PCL/rGO in THF samples were centrifuged for 1 h and filtered through a 0.45 µm filter
before GPC injection, in order to avoid rGO contamination of the GPC columns. The values of molecular
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weight distribution were obtained by the Empower 2 software (Waters). The molecular weights were
determined using a universal calibration curve related to polystyrene standards (Shodex, Waters,
Cerdanyola del Vallès, Spain) corrected by the Mark–Houwink–Sakura equation and the corresponding
PCL coefficients. Measurements were done in duplicate.
Thermal properties of the samples at 0 and 12 months of degradation were evaluated by
differential scanning calorimetry (DSC, DSC-131, SETARAM Instrumentation, Caluire, France) at
a scan rate of 10 ◦C/min. Samples (5–10 mg) were heated from room temperature to 100 ◦C (first
heating run). After 10 min stabilization at 100 ◦C, the samples were cooled down to 0 ◦C (cooling
run) and finally heated up again to 100 ◦C (second heating run) after stabilization. The degree of
crystallinity, χC (%) was calculated using Equation (2) [24], where ∆H0m (J·g−1) is the melting enthalpy
calculated from the second heating ramp, ∆H0m is the melting enthalpy for a 100% crystalline PCL
(139.5 J·g−1 [24]) and is the mass fraction of rGO in the PCL membrane.
χC = ∆Hm/
[
(1− β)× ∆H0m
]
(2)
The concentration of 6-hydroxycaproic acid (6-HCA), typically found as monomer degradation
product of PCL, was analyzed in the PBS medium where the membranes were submerged.
The UV–vis spectrophotometer (UV-1800 model, Shimadzu, Duisburg, Germany) was set at a 210 nm
wavelength [25]. Measurements of 6-HCA were carried out after 6 and 12 months of degradation time.
The presence of rGO nanoplatelets on the PBS medium and in the membrane matrix after 12 months
of degradation was analyzed (see Supplementary Materials).
Microscopic images of the membranes were obtained using a scanning electron microscope (SEM,
EVO MA 15, Carl Zeiss, Madrid, Spain) at a voltage of 20 kV, in order to determine the structure and
morphology of the surface and cross section of the membranes. Samples for the cross-section images
were frozen in liquid nitrogen to be fractured. All the samples were kept overnight at 30 ◦C under
vacuum, and were gold sputtered before examination. Moreover, visual inspection of the membrane
was recorded by taking photographs of the same membrane specimen periodically.
Before any testing, membranes were cleaned with UP water to remove any possible salt deposit.
Results are expressed as average ± standard deviation.
3. Results
3.1. Functional Properties
Figure 1 shows the mechanical properties of PCL and PCL/rGO membranes during the
degradation study. Figure 1A–D shows the Young modulus, yield point, ultimate tensile strength,
and ultimate strain, respectively. Mechanical tests were not feasible beyond 4 months, due to the
loss of mechanical stability. Specifically, the PCL membranes could be handled until 6 months, while
the PCL/rGO membranes could not be manipulated after 4 months. Videos confirming the poor
stability of the PCL and PCL/rGO membranes after 12 months of immersion in PBS are included in
the Supplementary Materials (Videos S1 and S2). During the hydrolytic degradation study, a gradual
reduction in the mechanical properties of both membranes was observed in the values of mechanical
parameters (Figure 1). Overall, at time 0, the presence of rGO in the polymer matrix significantly
reduced the mechanical properties in comparison to the plain PCL membranes. After 2 months, PCL
and PCL/rGO membranes showed homogeneous reduction of mechanical properties. For instance,
PCL membranes showed a reduction of mechanical properties in the range 57–62%, in a narrow
range for all the properties evaluated. The reduction of properties for PCL/rGO membranes was also
encountered, mainly around 63–68%, with the exception of the Young Modulus that suffered a 41%
drop. After 4 months, PCL/rGO still suffered similar reduction of mechanical properties as in previous
degradation times, while PCL membranes presented more disordered behavior: for instance, the yield
point barely changed while the Young modulus showed a 60% reduction.
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Figure 1. Mechanical properties of poly(ε-caprolactone) (PCL) and PCL/reduced graphene oxide 
(rGO) membranes. (A) ultimate tensile stress; (B) Young modulus; (C) ultimate strain; and (D) yield 
point for PCL and PCL/rGO membranes at 0, 2, and 4 months of degradation. (% values represent the 
reduction of the mechanical parameters between degradation times.) 
Figure 2 plots the change with the filtration time of the volumetric flux of BSA model solution 
through the PCL membranes for specimens that had been submerged in the hydrolytic bath for 0, 2, 
4, and 6 months, and PCL/rGO only at t = 0 months. BSA permeation tests for PCL/rGO membranes 
after in vitro degradation (t > 0 months) could not be performed because they could not withstand 
the transmembrane pressure of the filtration device. The membranes experienced a sharp flux drop 
during the first 2 h of filtration, with a reduction of 88.1 ± 2.9% in each point of degradation. 
Afterwards, it could be assumed that the flux reached a pseudo steady state (Inset of Figure 2). The 
BSA solution fluxes at this steady state were as follows: 143 ± 66 > 108 ± 5 > 103 ±3 > 80 ± 7 L·m−2·h−1 at 
0, 2, 4, and 6 months of degradation, respectively. Similarly, the BSA solution flux through PCL/rGO 
membranes at 0 months decayed from the initial value of 3620 ± 356 L m−2 h−1 to a stable flux of 190 ± 
68 L·m−2·h−1 (drop of 94.5 ± 2.4%).  
Figure 1. echanical properties of poly(ε-caprolactone) (PCL) and PCL/reduced graphene oxide (rGO)
membranes. (A) ultimate tensile stress; (B) Young modulus; (C) ultimate strain; and (D) yield point for
PCL and PCL/rGO membranes at 0, 2, and 4 months of degradation. (% values represent the reduction
of the mechanical parameters between degradation times.)
Figure 2 plots the change with the filtration time of the volu etric flux of BSA odel solution
through the P i s b erged in the hydrolytic bath for 0, 2, 4,
and 6 months, and PCL/rGO only at t = 0 onths. i r O e branes
after in itr i onths) could not be performed because they could not withs and the
transme brane pr ssure of the filtration device. Th membranes experienced a sharp flux drop du ing
the firs 2 h of filtrati n, with a reduction of 88.1 ± 2.9% in each poi t of degradation. Afterwards,
it could be assume that the flux re ched a pseudo ste dy state (Inset of Figure 2). The BSA solution
fluxes at this steady state were a follows: 143 ± 66 > 08 5 3 3 > 80 7 L·m−2·h−1 at 0, 2,
4, and 6 months of degrad tion, respectively. Similarly, the BSA solution flux t r rGO
membranes at 0 months decayed from the initial value of 3620 ± 356 L·m 2·h−1 to a stable flux of
190 ± 68 L·m−2·h−1 (drop of 94.5 ± 2.4%).
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including oligomers and monomer (6-HCA), that diffused out of the membrane matrix and 
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The progress of the number average molecular weight (Mn) with the degradation time is 
presented in Figure 3B. Both PCL and PCL/rGO membranes showed a progressive decrease in Mn. 
After two months of degradation, the Mn of the membranes suffered a significant reduction from the 
initial value of 75 ± 6 kDa to 61 ± 7 kDa for PCL membranes (drop of 19%), and to 49 kDa for 
PCL/rGO membranes (drop of 35%). At 12 months, Mn decreased further to 33 ± 0.04 kDa (56%) for 
PCL membranes, and to 27 ± 0.75 kDa (65%) for PCL/rGO membranes. The polydispersity index 
(PDI) of the molecular weight distribution remained almost constant during the degradation period, 
i.e., PDI values of 1.42 at t = 0 months and 1.47 at t = 12 months for PCL films, and 1.34 at t = 12 
months for PCL/rGO films were obtained (Figure 3B). Regarding the hydrolysis kinetics of 
polymers, it usually follows second order reaction kinetics, that is, the rate of the reaction is 
proportional to the concentration of water and the concentration of chemical bonds susceptible of 
hydrolysis, i.e., carboxylic bonds for polyesters [27] (see Equations (S1) and (S2) in Supplementary 
Materials). Figure S1 (Supplementary Materials) shows good agreement of the fitting of the 
experimental data to 1/Mn vs t, which indicates that the hydrolysis of our membranes proceeded 
according to second order kinetics. Moreover, in Figure S1, it was shown that the hydrolysis kinetics 
of PCL/rGO membranes was only slightly faster (approximately 1.4 times) than the hydrolytic 
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Figure 2. Total flux decay of BSA model solution of average values of PCL membranes during 240 min
at different times of degradation. Flux data for PCL/rGO membrane at t = 0 months were also included
(deviation bars not shown for the shake of clarity). Inset shows the values of BSA solution flux at
steady state for PCL and PCL/rGO membranes at 0, 2, 4, and 6 months of degradation.
3.2. Physical–Chemical Properties Characterization
Figure 3A shows the hydrolysis degradation pathway of the PCL polymer. The cleavage of the
ester bonds of PCL is produced upon the reaction with water, forming carboxyl end-groups, and
the progressive reduction of the average molecular size to give water-soluble degradation products,
including oligomers and monomer (6-HCA), that diffused out of the membrane matrix and solubilized
in the PBS medium [26].
The progress of the number average molecular weight (Mn) with the degradation time is presented
in Figure 3B. Both PCL and PCL/rGO membranes showed a progressive decrease in Mn. After two
months of degradation, the Mn of the membranes suffered a significant reduction from the initial value
of 75± 6 kDa to 61± 7 kDa for PCL membranes (drop of 19%), and to 49 kDa for PCL/rGO membranes
(drop of 35%). At 12 months, Mn decreased further to 33 ± 0.04 kDa (56%) for PCL membranes, and
to 27 ± 0.75 kDa (65%) for PCL/rGO membranes. The polydispersity index (PDI) of the molecular
weight distribution remained almost constant during the degradation period, i.e., PDI values of 1.42 at
t = 0 months and 1.47 at t = 12 months for PCL films, and 1.34 at t = 12 months for PCL/rGO films
were obtained (Figure 3B). Regarding the hydrolysis kinetics of polymers, it usually follows second
order reaction kinetics, that is, the rate of the reaction is proportional to the concentration of water and
the concentration of chemical bonds susceptible of hydrolysis, i.e., carboxylic bonds for polyesters [27]
(see Equations (S1) and (S2) in Supplementary Materials). Figure S1 (Supplementary Materials) shows
good agreement of the fitting of the experimental data to 1/Mn vs t, which indicates that the hydrolysis
of our membranes proceeded according to second order kinetics. Moreover, in Figure S1, it was shown
that the hydrolysis kinetics of PCL/rGO membranes was only slightly faster (approximately 1.4 times)
than the hydrolytic kinetics of PCL membranes.
Membranes 2018, 8, 12 7 of 14
Membranes 2018, 8, x FOR PEER REVIEW  7 of 14 
 
 
Figure 3. (A) Scheme of the PCL hydrolytic degradation process, adapted from Woodruff et al. [14]; 
(B) Change of the number average molecular weight (Mn, filled symbols) and polydispersity index 
(PDI, empty symbols); and (C) mass of degradation product 6-HCA in the PBS formed during 
degradation process of PCL and PCL/rGO membranes. 
Figure 3C illustrates the concentration of 6-HCA per unit mass of membrane released to the PBS 
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Materials). It can also be appreciated that the precipitated rGO was qualitatively more abundant 
(higher mass concentration) in the samples corresponding to 12 months of degradation than in the 
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Figure 3. (A) Scheme of the PCL hydrolytic degradation process, adapted from Woodruff et al. [14];
(B) Change of the number average molecular weight (Mn, filled symbols) and polydispersity index
(PDI, empty symbols); and (C) mass of degradation product 6-HCA in the PBS formed during
degradation process of PCL and PCL/rGO membranes.
Figure 3C illustrates the concentration of 6-HCA per unit mass of membrane released to the PBS
medium after 6 and 12 months of hydrolytic degradation. The concentration of the 6-HCA in the PBS
increased significantly with the degradation time, as expected. The 6-HCA concentration in the PBS
medium was higher for PCL/rGO than for PCL membranes, in good agreement with the evolution
of the molecular size observed in Figure 3B. The presence of 6-HCA in the buffer solutions barely
affected the pH (data not shown). During the degradation test, an attempt to evaluate what happened
with the rGO nanoplatelets of the PCL/rGO membranes was done. After re-dissolving the PCL/rGO
membranes in THF, the presence of rGO nanoplatelets in the membranes was visually confirmed at 0
months and after 12 months of degradation (see Figure S2 of the Supplementary Materials). It can also
be appreciated that the precipitated rGO was qualitatively more abundant (higher mass concentration)
in the samples corresponding to 12 months of degradation than in the PCL/rGO membranes at t = 0.
Moreover, the UV–vis spectrum of the PBS that contained the PCL/rGO membranes during 12 months
of degradation did not show the rGO representative peak around 270 nm [28]. These qualitative results
led us to think that rGO mainly remained in the solid material of the PCL/rGO membranes.
Furthermore, Figure 4 represents the DSC thermograms of the PCL (A) and PCL/rGO membranes
(B) at 0 and 12 months. The initial value of the melting temperature (Tm) (0 months) was 62.10 ◦C
for PCL membranes and 60.36 ◦C for PCL/rGO membranes. After 12 months of degradation time,
Tm increased to 64.54 ◦C for PCL and to 64.72 ◦C for PCL/rGO membranes. The crystallization
temperature, Tc, increased as well during the degradation period in both types of membranes, from
31.75 ◦C to 32.63 ◦C for PCL, and from 32.45 ◦C to 35.00 ◦C for PCL/rGO. The initial χC of PCL/rGO
was 41%, and increased to 46% after 12 months. Meanwhile, PCL membranes crystallinity varied from
35% to 44%. The higher crystallinity of the degraded samples pointed to the preferential hydrolytic
attack of the amorphous polymer phase.
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Figure 4. DSC thermogram of PCL (A) and PCL/rGO (B); embranes at 0 and 12 months
of degradation.
The membranes did not suffer any significant reduction in dimensions (width, length, and
thickness) during the degradation time (Figure S3, Supplementary Materials). Regarding the
microscopic morphology, SEM images of the surface and cross section of the PCL and PCL/rGO
membranes at 0, 2, and 12 months of hydrolytic degradation are illustrated in Figure 5. Overall, a
noticeable change in the morphology of the membranes can be observed. The surface of both PCL
and PCL/rGO membranes eroded slightly from 0 to 2 months, and then very notably after 12 months
of degradation. The morphological degradation of the internal structure of the membranes was also
evident, as shown in the SEM cross section images.
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degradation. The scale bars represent 10 µm.
4. Discussion
PCL/rGO and control PCL membranes fabricated in this work degraded continuously under the
presence of PBS simulating in vitro culture conditions. The molecular weight presented a progressive
reduction (Figure 3B), produced by the hydrolytic chain scission of the ester group due to water
penetration. The degradation kinetics of our membranes corresponded to second order kinetics,
in agreement with typical hydrolysis of large molecular weight polyesters [27]. Also, the maintenance
of PDI values (Figure 3B) during the degradation period indicated that all the carboxylic bonds of the
polymer chain had equal reactivity, in agreement with the obtained second order kinetics. In spite of
the hydrophobic character of the rGO nanoplatelets [10], a slight, though not significant, acceleration
of the hydrolytic degradation for PCL/rGO membrane was observed in comparison to the plain
PCL membranes in terms of molecular weight change. The monomer 6-HCA, as the main indicator
of degradation products, was released and diffused into the buffer media (Figure 3C). Therefore,
its concentration progressively increased with the degradation period, and showed slightly higher
values for buffer media containing PCL/rGO membranes than for PCL membranes, in agreement with
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the results of the molecular weight degradation kinetics. Moreover, the higher degree of crystallinity,
as well as the increase on the thermal properties after 12 months of degradation, pointed to the
preferential hydrolytic attack of the polymer amorphous region in both membranes [17]. Finally,
the internal morphology of the membranes suffered a clear change (Figure 5), while the dimensions
of the membranes remained constant during the degradation process (Figure S3). According to the
aforementioned results, in the present work, degradation of the membranes proceeded via bulk
degradation mechanism [29]. Bulk degradation mechanism of PCL networks was also reported
by [22] under similar hydrolytic degradation conditions. The similar tendencies observed in the
present work on the molecular weight reduction for PCL and PCL/rGO membranes, points to the
high porosity of the fabricated membranes as the main cause for the bulk hydrolysis mechanism.
The porous internal morphology favored the water penetration and the outward diffusion of the
degradation products [30]. In comparison to other reported works with similar molecular weight
(PCL 80 kDa) [31,32], our fabricated membranes demonstrated an accelerated degradation rate.
All mid- and end-point degradation products must be thoroughly investigated for possible
immunogenic reactions [33]. During the progress of the polymer degradation, it was observed
that the rGO nanoplatelets remained mainly in the membrane. This was consistent with the
results of Murray et al. [21]. They also reported that PCL/rGO blended materials increased the relative
concentration of rGO during enzymatic degradation from 5 w/w % to 19 w/w %, and did not observe
cytotoxicity on L-929 fibroblast cells growing for short periods. In our previous work [16], we also
observed a positive biocompatibility on glioblastoma cells of the PCL membranes containing rGO
nanomaterials after 14 days of culture. These null cytotoxic results are also in agreement with the low
pH acidification of the buffer solution observed in our system (results not shown) that would not likely
turn into a negative cellular response [34].
The presence of rGO nanoplatelets in the polymer matrix significantly reduced the mechanical
integrity of the membranes at any degradation time. This effect was attributed to a restriction of the
mobility of the polymer chains [24], and to defects and gaps created by the presence of rGO in the
polymer matrix [35]. Also, the presence of rGO caused a faster and more intense loss of mechanical
properties and structural stability for PCL/rGO membranes in contrast to PCL membranes (Figure 1
and Videos S1 and S2) that could also be explained by the same causes that decreased the initial
mechanical properties of PCL/rGO in contrast to PCL membranes, as previously explained. Despite
the fast loss of mechanical properties of the PCL/rGO membranes, after 4 months of degradation,
these materials still comply sufficiently with the mechanical properties required for materials to sustain
neural tissues. Actually, the mechanical stiffness of the 4-month degraded membranes are closer to
the values of the hydrogels typically employed as scaffold materials for neural tissue regeneration,
i.e., Matrigel [36], modified gelatin [37], polyethylene glycol, or alginate hydrogels [38,39]. For instance,
a broad range of Young modulus values, i.e., in the order of 0.2–20 kPa for alginate hydrogel 40 and
0.1–1.2 MPa for modified gelatin [37], can be found for these materials. Nevertheless, although Matrigel
is one of the most employed materials for scaffolds in neural adhesion and proliferation, its relatively
weak mechanical strength and significant degradation over long-term culture has been considered a
drawback for its use in in vitro neural models [40]. Apart from the effect of the membrane stiffness
on the induction of mechanical cues over the cells, it is envisaged that the mechanical properties loss
of the material could be substituted by the tissue mechanical stability if there is an equivalent rate of
membrane structural disintegration and tissue regeneration. In the field of neural tissue regeneration,
in vitro models of cerebral organoids require only 8–10 days for the appearance of neural identity
and 20–30 days for the formation of defined brain regions [36]. Mahoney and Anseth [39] confirmed
the suitable use of polyethylene glycol hydrogels to act as cell carriers for transplantation into the
central nervous system (CNS), with an accelerated loss of mechanical properties in 12 days. In general,
an adequate scaffold material should lose mechanical properties at an approximate rate of 8%/week
during in vivo degradation [41], and neural scaffold materials would ideally degrade over a period of
2–8 weeks via hydrolysis, ion exchange, or through enzymatic reactions [33]. All the previous works
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support the idea that the rate of neural tissue regeneration could be comparable to the degradation
rate behavior of our PCL and mainly to PCL/rGO membranes. Actually, preliminary experiments
on neural progenitor cells (NPC) differentiation and maturation have been performed for 20 days on
PCL and PCL/rGO membranes, showing promising cell coverage (unpublished data) and adequate
structural integrity for the manipulation.
Regarding the behavior of the BSA solution flux through the membranes, the initial pronounced
reduction of the flux (Figure 2) was associated with the internal fouling due to BSA protein adhesion
to the pore walls [16]. The progressive decrease of the steady-state BSA fluxes for PCL membranes
during the degradation time could be attributed to the gradual loss of structural integrity under
hydrodynamic pressure, causing the membrane compaction, and therefore, the pore size reduction
during filtration assays [30]. Regardless, the significant reduction of the nutrient flux at steady state,
PCL and PCL/rGO membranes still displayed a comparable total BSA solution flux to that reported
by Bettahalli et al. [42] for commercial poly(ether-sulfone) hollow fibers, theoretically sufficient to
supply the needs of glucose consumption to more than three layers of cells under confluence in a
perfusion bioreactor.
5. Conclusions
The present work reports on the evaluation of the hydrolytic degradation of novel PCL/rGO
porous membranes fabricated by phase inversion technique. The hydrolytic degradation during a long
term period of 12 months of these PCL/rGO membranes was evaluated in this work, in order to study
the membrane capacity to act as scaffold for in in vitro bioreactors for neural tissue regeneration and
its further use as in vitro human neural models.
Both, PLC/rGO membranes and PCL membranes (control membranes) exhibited a fast
degradation rate. This work demonstrates that the high porous membrane structure obtained as
a result of the phase inversion manufacturing technique was the main factor on the acceleration of
the degradation, as it could promote water penetration, and therefore facilitate the bulk hydrolytic
mechanism of the membranes. The molecular weight decreased, following second order kinetic rate,
characteristic of these types of polyesters of large molecular weight. As a result, there was a loss
of the membrane’s mechanical resistance, an enhancement of the crystallinity, and the formation of
PCL degradation products, such as the monomer 6-hydroxycaproic acid, released to the hydrolytic
media. Besides the aforementioned alterations, the changes in the porous morphology without any
observable modification of the sample dimensions led to the conclusion that degradation proceeded
via bulk hydrolysis mechanism. The introduction of rGO nanoplatelets into the PCL matrix only
slightly accelerated the degradation rate. Particularly, the presence of rGO reduced significantly the
mechanical stability of the membranes at all degradation times. However, PCL/rGO membranes
still procured sufficient mechanical properties to theoretically comply with the specifications of the
neural tissue regeneration. Besides, the degradation rate of the membranes herein reported would
perfectly fit the rate of neural tissue regeneration that would need around 1 month to be completed.
The rGO nanoplatelets remained preferentially in the polymer matrix of the membrane during the
degradation process and, according to previous works, the degradation products of similar PCL/rGO
blended materials should not alter the cytotoxicity of the buffer solution. The high porosity that
induces exceptional BSA solution flux let us deem that PCL/rGO membranes would be promising
candidates to be used as scaffolds for neural tissue regeneration in perfusion bioreactors. Finally, it has
to be remarked that experiments to evaluate the performance of the PCL/rGO membranes on dynamic
neural cell culture, as well as the assessment of the potential of PCL/rGO membranes to induce stem
cell differentiation into neural tissue, are currently under progress.
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Supplementary Materials: The following are available online at www.mdpi.com/2077-0375/8/12/s1, Video S1:
Mechanical behavior of PCL membranes after 12 months of hydrolytic degradation; Video S2: Mechanical behavior
of PCL/rGO membranes after 12 months of hydrolytic degradation; Equations (S1) and (S2) demonstrating
simplifications and fitting of the experimental data of change of the polymer molecular weight with degradation
time to a 2nd order hydrolysis kinetics and Figure S1: Kinetics of the hydrolysis of PCL and PCL/rGO membranes.
Fitting of the molecular weight to the second order hydrolysis kinetics (Equation (S2)) is depicted (dotted lines).
Figure S2: Photographs showing the rGO content at 0 and 12 months of degradation of the PCL/rGO membranes.
Figure S3: Photographs showing the visual aspect of the wet PCL and PCL/rGO membranes at 0 and 12 months
of degradation.
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